13th Edition of International Conference on Neurology and Brain Disorders
October 19-21, 2026
Congenital Myopathies
Congenital myopathies are a rare group of genetic neuromuscular diseases that are present at birth. In most cases, the cause is unknown. Symptoms typically include muscle weakness, stiffness, and joint contractures, as well as hypotonia, which can cause developmental delays. Other common features may include scoliosis, respiratory problems, swallowing difficulties, and cardiac issues. Diagnosis is often challenging as there are currently no laboratory tests or tools that can pinpoint congenital myopathies. Diagnosis often requires a combination of examinations, including physical, neurological, and musculoskeletal evaluations, as well as electrodiagnostic tests, medical imaging, and a muscle biopsy. Treatment for congenital myopathies is focused on managing symptoms and improving quality of life. It may involve physical therapy, occupational therapy, assistive devices, medications, and surgery, depending on the individual’s needs. As there is no cure, treatment plans focus on management and prevention of further complications. Although often rare, congenital myopathies can be life-threatening. Early and accurate diagnosis is critical for providing the best care possible. Fortunately, research such as whole-exome sequencing is making it possible to diagnose these conditions faster and with more accuracy. With improved diagnosis and treatment options, the quality of life for people living with congenital myopathies is improving.
Joe Sam Robinson
Mercer University, United States
Robert B Slocum
University of Kentucky HealthCare, United States
George Diaz
Memorial Healthcare Systems, United StatesSubmit your abstract Today
Title : Managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Narrative medicine: A communication therapy for the communication disorder of Functional Seizures (FS) [also known as Psychogenic Non-Epileptic Seizures (PNES)]
Robert B Slocum, University of Kentucky HealthCare, United States
Title : Atypical presentation of Juvenile myoclonic epilepsy in a 16-year-old female: A Case Report
George Diaz, Memorial Healthcare Systems, United States
Title : Nanoparticles passing the blood brain barrier to treat cancer, infection, and more
Thomas J Webster, Brown University, United States
Title : Transcranial painless neurorehabilitation scalp acupuncture electrical stimulation for neuroregulation of autism spectrum disorder
Zhenhuan Liu, Guangzhou University Chinese Medicine, China
Title : Effects of prenatal androgen exposure on Purkinje cell morphology in the cerebellum of female rats
Kiran Ghotra, Lake Erie College of Osteopathic Medicine, United States